N@N

Liav Abraham Downgraded (TEVA) to Hold on, Aug 16th, 2017

Liav Abraham of Citigroup, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Aug 16th, 2017.

Liav has made no other calls on TEVA in the last 4 months.

There are 9 other peers that have a rating on TEVA. Out of the 9 peers that are also analyzing TEVA, 7 agree with Liav's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $23 on, Monday, August 7th, 2017
• Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
• Vamil Divan of "Credit Suisse" Downgraded from Buy to Hold on, Friday, August 4th, 2017
• Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
• Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017
• Irina Rivkind Koffler of "Mizuho" Upgraded from Sell to Hold on, Friday, June 16th, 2017
• Louise Chen of "Cantor Fitzgerald" Initiated at Hold and Held Target at $31 on, Thursday, June 15th, 2017

These are the ratings of the 2 analyists that currently disagree with Liav

---

• David Risinger of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $16 on, Monday, August 7th, 2017
• Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017

Contributing Sources

---